北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第一临床医学院  > 期刊论文
学科主题: 临床医学
题名:
Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study
作者: Judlin, P.1; Liao, Q.2; Liu, Z.2; Reimnitz, P.3; Hampel, B.4; Arvis, P.5
关键词: Levofloxacin ; metronidazole ; moxifloxacin ; uncomplicated pelvic inflammatory disease
刊名: BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
发表日期: 2010-11-01
DOI: 10.1111/j.1471-0528.2010.02687.x
卷: 117, 期:12, 页:1475-1484
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Obstetrics & Gynecology
研究领域[WOS]: Obstetrics & Gynecology
关键词[WOS]: SEXUALLY-TRANSMITTED-DISEASES ; IN-VITRO ACTIVITY ; NEISSERIA-GONORRHOEAE ; OUTPATIENT TREATMENT ; RANDOMIZED-TRIAL ; BAY 12-8039 ; TREATMENT-GUIDELINES ; 8-METHOXY QUINOLONE ; CLINICAL-TRIALS ; DOUBLE-BLIND
英文摘要:

Objective

To evaluate the efficacy and safety of moxifloxacin versus levofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease (uPID) in Asia.

Design

Prospective, randomised, double-blind, double-dummy, parallel-group study.

Setting

Multicentre, multinational study in the inpatient and/or outpatient setting.

Population

Women (aged >= 18 years) with uPID (defined as PID with no pelvic or tubo-ovarian abscess on pelvic ultrasonography and at laparoscopic examination) and not requiring intravenous treatment.

Methods

Women received a 14-day course of either oral moxifloxacin, 400 mg once daily, or oral levofloxacin, 500 mg once daily, plus oral metronidazole, 500 mg twice daily. Additionally, a single dose of ceftriaxone, 250 mg intramuscularly, was administered to women who had a positive screening test for Neisseria gonorrhoeae.

Main outcome measures

The primary measure of efficacy was clinical response at test-of-cure (TOC) (7-14 days after the last dose of study drug) in the per-protocol population. Noninferiority of moxifloxacin to the comparator regimen was demonstrated if lower limit of 95% CI was >-15%. Other measures were clinical response during therapy and at 4-week follow up, microbiological response at TOC, and safety.

Results

A total of 460 women were randomised to the study. For the primary measure of efficacy (clinical cure at TOC), moxifloxacin was noninferior to levofloxacin plus metronidazole (moxifloxacin: 152/194, 78.4%; comparator 155/190, 81.6%; 95% CI -10.7 to +4.9). The most commonly isolated pathogens at baseline included Neisseria gonorrhoeae, Chlamydia trachomatis, Escherichia coli, Staphylococcus aureus, Peptostreptococcus spp., Proteus mirabilis, Streptococcus agalactiae and Klebsiella pneumoniae. Bacteriological success rates were high and comparable between treatment arms (microbiologically valid populations, moxifloxacin 27/30, 90.0%; comparator 22/26, 84.6%; 95% CI -12.7 to +20.3). Both treatments were well tolerated.

Conclusions

Moxifloxacin monotherapy, 400 mg once daily for 14 days, is an effective and well-tolerated oral treatment for women with uPID.

语种: 英语
项目资助者: GlaxoSmithKline ; Sanofi-Pasteur-MSD ; Bayer HealthCare ; Bayer HealthCare AG, Leverkusen, Germany
WOS记录号: WOS:000282878800006
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/65447
Appears in Collections:北京大学第一临床医学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Bayer Schering Pharma, Loos, France
2.Bayer Schering Pharma, Berlin, Germany
3.Bayer Vital GmbH, Leverkusen, Germany
4.Univ Henri Poincare, Maternite Reg Univ Nancy, F-54042 Nancy, France
5.Peking Univ, Hosp 1, Dept Obstet & Gynaecol, Beijing, Peoples R China

Recommended Citation:
Judlin, P.,Liao, Q.,Liu, Z.,et al. Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study[J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY,2010,117(12):1475-1484.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Judlin, P.]'s Articles
[Liao, Q.]'s Articles
[Liu, Z.]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Judlin, P.]‘s Articles
[Liao, Q.]‘s Articles
[Liu, Z.]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
Email:  *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace